Cooney E. Novartis unit teams up with medical marijuana producer, marking milestone for pharma. STAT Daily Recap 2018:18 de diciembre. [Ref.ID 102888]

Caughey GE, Gabb GM, Ronson S, Ward M, Beukelman T, Hill CL, Limaye V. Association of statin exposure with histologically confirmed idiopathic inflammatory myositis in an Australian population. JAMA Intern Med 2018;178:septiembre. [Ref.ID 102883]

Lalic S, Gisev N, Bell JS, Korhonen MJ, Ilomäki J. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia . Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102804]

Anónimo. Australia becomes fourth nation to allow medicinal marijuana exports. DIA Daily 2018:4 de enero. [Ref.ID 102442]

Admassie E, Chalmers L, Bereznicki LR. Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study. Eur J Clin Pharmacol 2017;73:1681-9. [Ref.ID 102181]

Anónimo. Health officials predict rough flu season, point to potentially less effective vaccine. DIA Daily 2017:17. [Ref.ID 102161]

Fanning L, Ilomäki J, Bell JS, Darzinš P. The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation. Eur J Clin Pharmacol 2017;73:1427-36. [Ref.ID 102129]

Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson S-A. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol 2017;83:2581-8. [Ref.ID 102118]

Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, Bereznicki LR. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 2017;40:597-606. [Ref.ID 101969]

Walter SR, Day RO, Gallego B, Westbrook JI. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia. Br J Clin Pharmacol 2017;83:416-26. [Ref.ID 101933]

Ralph AP, Noonan S, Boardman C, Halkon C, Currie BJ. Prescribing for people with acute rheumatic fever. Australian Prescriber 2017;40:70-5. [Ref.ID 101520]

McCall C. Momentum grows for medical use of cannabis. Lancet 2015;386:1615-6. [Ref.ID 99633]

Moseley AM, Beckenkamp PR, Haas M, Herbert RD, Lin C-WC, for the EXACT Team. Rehabilitation after immobilization for ankle fracture: the EXACT randomized clinical trial. JAMA 2015;314:1376-85. [Ref.ID 99545]

Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology 2015;22:920-30. [Ref.ID 99443]

Sohn M, Talbert J, Blumenschein K, Moga DC. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents. Pharmacoepidemiol Drug Saf 2015;24:583-91. [Ref.ID 99177]

Leach MJ, Pratt NL, Roughead EE. Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study. Pharmacoepidemiol Drug Saf 2015;24:576-82. [Ref.ID 99176]

Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, John S, Thynne T, Bell JS. Statin use and pain in older people with cancer: a cross-sectional study. J Am Geriatr Soc 2014;62:1900-5. [Ref.ID 98397]

Coopes.A. Company withholds lifesaving drug in row with Australian government over its use. BMJ 2014;349:g5869. [Ref.ID 98276]

Clarke R, Bennett D. Folate and prevention of neural tube defects. BMJ 2014;349:g4810. [Ref.ID 98164]

Anónimo. Larger concerns with antipsychotics in kids. NPS MedicineWise 2014:23 de septiembre. [Ref.ID 98099]